Example #1: On October 31, 2003, the New York District Court entered a Final Judgment As To Defendant JPMSI (the “ JPMSI Research Analysts Final Judgment ”) that, among other things, enjoined JPMSI, directly or through its officers, directors, agents and employees, from violating then NASD Conduct Rules 2110, 2210, and 3010 and NYSE Rules 342, 401, 472, and 476 (the “ JPMSI Research Analysts Injunction ”).
Expected output: 'entities: [{'span': 'New York District Court', 'entity': 'Court'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'JPMSI Research Analysts Final Judgment', 'entity': 'Miscellaneous'}, {'span': 'NASD Conduct Rules', 'entity': 'Legislation/Act'}, {'span': 'NYSE Rules', 'entity': 'Legislation/Act'}, {'span': 'JPMSI Research Analysts Injunction', 'entity': 'Miscellaneous'}]'

Example #2: IPOs On October 1, 2003, the Commission filed a complaint (the “ IPO Complaint ”) against J.P. Morgan Securities Inc. (predecessor to JPMS, “ JPMSI ”) in the United States District Court for the District of Columbia (the “ D.C. District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'IPO Complaint', 'entity': 'Miscellaneous'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}, {'span': 'JPMS', 'entity': 'Business'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'United States District Court for the District of Columbia', 'entity': 'Court'}, {'span': 'D.C. District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #3: Research Analysts - JPMSI On April 28, 2003, the Commission filed a complaint (the “ JPMSI Research Analysts Complaint ”) against JPMSI in the United States District Court for the Southern District of New York (the “ New York District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'JPMSI', 'entity': 'Business'}, {'span': 'JPMSI Research Analysts Complaint', 'entity': 'Miscellaneous'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}, {'span': 'New York District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}]'

Example #4: The Board of Directors The Corporate Trust Services division of Wells Fargo Bank, National Association: We have examined management s assessment, included in the accompanying Assessment of Compliance with Applicable Servicing Criteria, that The Corporate Trust Services division of Wells Fargo Bank, National Association (the Company) complied with the servicing criteria set forth in Item 1122 (d) of the Securities and Exchange Commission s Regulation AB for publicly-issued (i.e., transaction-level reporting initially required under the Securities Exchange Act of 1934, as amended) residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities, for which the Company provides master servicing, trustee, securities administration, or paying agent services, excluding transactions issued by any agency or instrumentality of the U.S. government or any government sponsored entity and further excluding the transactions issued prior to 2006 for which Wells Fargo outsources all material servicing activities (as defined by Regulation AB) (the Platform), except for servicing criteria 1122 (d) (4) (ii), 1122 (d) (4) (iv), 1122 (d) (4) (v), 1122 (d) (4) (viii), 1122 (d) (4) (ix), 1122 (d) (4) (x), 1122 (d) (4) (xi), 1122 (d) (4) (xii), and 1122 (d) (4) (xiii), which the Company has determined are not applicable to the activities it performs with respect to the Platform, as of and for the twelve months ended December 31, 2009.
Expected output: 'entities: [{'span': 'Wells Fargo Bank, National Association', 'entity': 'Business'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Regulation AB', 'entity': 'Legislation/Act'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'U.S.', 'entity': 'Location'}, {'span': 'Wells Fargo', 'entity': 'Business'}]'

Example #5: Morgan Securities executed on June 17, 2011, a Consent of Defendant J.P. Morgan Securities (the “ Consent ”), in which J.P. Morgan Securities neither admitted nor denied any of the allegations (except as to personal and subject matter jurisdiction) in a complaint filed by the Commission, but in which it consented to the entry of a final judgment (“ Final Judgment ”) against it by the United States District Court for the Southern District of New York (the “ Court ”).
Expected output: 'entities: [{'span': 'Morgan Securities', 'entity': 'Business'}, {'span': 'J.P. Morgan Securities', 'entity': 'Business'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #6: The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys ’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.
Expected output: 'entities: [{'span': 'Court of Chancery of the State of Delaware', 'entity': 'Court'}, {'span': 'Court of Chancery', 'entity': 'Court'}]'

Example #7: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #8: The undersigned hereby makes, constitutes and appoints each of Michael J. Berner and Douglas W. Ambrose as the undersigned ’ s true and lawful authorized representative, attorney-in-fact and agent, each with the power individually to execute for and on behalf of the undersigned and to file with and deliver to the United States Securities and Exchange Commission and any other authority or party required or entitled to receive the same: (a) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16 (a) of the Securities Exchange Act of 1934, as amended (the “ 1934 Act ”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder.
Expected output: 'entities: [{'span': 'Michael J. Berner', 'entity': 'Person'}, {'span': 'Douglas W. Ambrose', 'entity': 'Person'}, {'span': 'United States Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Forms 3, 4 and 5', 'entity': 'Miscellaneous'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': '1934 Act', 'entity': 'Legislation/Act'}, {'span': 'Schedule 13D', 'entity': 'Miscellaneous'}, {'span': 'Schedule 13G', 'entity': 'Miscellaneous'}]'

Example #9: Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, to Kenneth L. Waggoner, Executive Vice President Legal, General Counsel and Director of the Company, 12526 High Bluff Drive, Suite 155, San Diego, California USA.
Expected output: 'entities: [{'span': 'Kenneth L. Waggoner', 'entity': 'Person'}, {'span': 'High Bluff Drive', 'entity': 'Location'}, {'span': 'San Diego', 'entity': 'Location'}, {'span': 'California', 'entity': 'Location'}, {'span': 'USA', 'entity': 'Location'}]'

Example #10: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #11: Shareholders of a Fund who execute proxies may revoke them at any time before they are voted by filing with that Fund a written notice of revocation, by delivering a duly executed proxy bearing a later date, or by attending the Annual Meeting and voting in person.
Expected output: 'entities: []'

Example #12: The cost of preparing, printing and mailing the enclosed proxy, accompanying notice and proxy statement and all other costs in connection with the solicitation of proxies will be paid by the Funds pro rata based on the number of shareholder accounts.
Expected output: 'entities: []'

Example #13: We have acted as special counsel to Regency Energy Partners LP, a Delaware limited partnership (the Partnership), Regency Energy Finance Corp., a Delaware corporation (Regency Finance and, together with the Partnership, the Issuers), and the entities listed on Schedule I hereto (collectively, the Guarantors), in connection with the filing on the date hereof with the Securities and Exchange Commission (the Commission) of Post-Effective Amendment No. 1 (the Amendment) to the registration statement on Form S-3 (File No. 333-169901) (the Registration Statement) under the Securities Act of 1933, as amended (the Act).
Expected output: 'entities: [{'span': 'Regency Energy Partners LP', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}, {'span': 'Regency Energy Finance Corp.', 'entity': 'Business'}, {'span': 'Regency Finance', 'entity': 'Business'}, {'span': 'Schedule I', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Form S-3', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}]'

Example #14: The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), and in accordance therewith files reports, proxy statements and other information including annual and quarterly reports on Form 10-K and 10-Q (the “ 1934 Act Filings ”) with the Securities and Exchange Commission (the “ Commission ”).
Expected output: 'entities: [{'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': '10-Q', 'entity': 'Miscellaneous'}, {'span': '1934 Act Filings', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #15: Audit Committee members shall be independent of the Funds and free of any relationship that, in the opinion of the Directors/Trustees, would interfere with their exercise of independent judgment as an Audit Committee member.
Expected output: 'entities: []'

Example #16: The inspectors of election will treat abstentions and broker non-votes (i.e., shares held by brokers or nominees, typically in street name, as to which (i) instructions have not been received from the beneficial owners or persons entitled to vote and (ii) the broker or nominee does not have discretionary voting power on a particular matter) as present for purposes of determining a quorum.
Expected output: 'entities: []'

Example #17: The Audit Committee shall assist the Board in oversight and monitoring of (1) the accounting and reporting policies, processes and practices, and the audits of the financial statements, of the Funds; (2) the quality and integrity of the financial statements of the Funds; (3) the Funds compliance with legal and regulatory requirements, (4) the independent auditors qualifications, performance and independence; and (5) oversight of the Pricing Procedures of the Funds and the Valuation Group.
Expected output: 'entities: []'

Example #18: With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals for the Ninth Circuit.
Expected output: 'entities: [{'span': 'United States Court of Appeals for the Ninth Circuit', 'entity': 'Court'}]'

Example #19: Rule 452 permits proportionate voting of Preferred Shares with respect to a particular item if, among other things, (i) a minimum of 30 % of the Preferred Shares or shares of a series of Preferred Shares outstanding has been voted by the holders of such shares with respect to such item and (ii) less than 10 % of the Preferred Shares or shares of a series of Preferred Shares outstanding has been voted by the holders of such shares against such item.
Expected output: 'entities: []'

Example #20: (b) a fee of $ 2,500 per meeting for attendance in person where such in-person attendance is required and $ 1,500 per meeting for attendance by telephone or in person where in-person attendance is not required at a special, non-regularly scheduled board meeting; (c) a fee of $ 2,000 per meeting for attendance in person or $ 1,500 per meeting for attendance by telephone at an audit committee meeting; (d) a fee of $ 2,000 per meeting for attendance at a regularly scheduled compliance, risk management and regulatory oversight committee meeting for regular quarterly meetings and $ 1,000 per meeting for attendance of other, non-quarterly meetings; (e) a fee of $ 1,000 per meeting for attendance in person or by telephone for a meeting of the dividend committee; and (f) a fee of $ 500 per meeting for attendance in person at all other committee meetings, $ 1,000 for attendance at shareholder meetings, on a day on which no regularly scheduled board meeting is held in which in-person attendance is required, $ 250 per meeting for attendance by telephone at all other committee meetings (excluding shareholder meetings) where in-person attendance is not required and $ 100 per meeting when the executive committee acts as pricing committee for IPOs, plus, in each case, expenses incurred in attending such meetings.
Expected output: 'entities: []'

